What is supergravy and why is it necessary?
Rubius Therapeutics biotech startup wants to create superkrewe that would be able to treat a rare disease and even cancer. The company has already received $ 220 million for research.
Rubius company wants to develop Therapeutics targeted therapy against diseases, using red blood cells. According to the Director of a startup Straight Torben Nielsen, a new drug would be called “superkraut” because it will be based on red blood cells, not chemicals or other synthetic materials.
Rubius plans to provide red blood cells therapeutic proteins that can be modified for combat certain diseases.
After this procedure, this blood is poured into the patient’s body for treatment. Overall, superbrawl will be less than one percent of the total volume of blood in the human body.Newshealth Myths that it’s time to stop believing
The company wants to develop a therapy supercraft that will replace the missing enzymes in patients suffering from rare diseases, and to treat cancer and autoimmune diseases like lupus and type I diabetes. However, such therapy may not be personalized. The company claims that it needs only one universal donor (first blood) from which it is possible to obtain sufficient therapeutic doses, which is enough for thousands of different patients.
Rubius in June 2017, has received $ 120 million from investors, and recently received an additional 100 million. Of course, the new medication will be available soon. At first it is necessary to develop and then carry out clinical tests, but the company is clearly serious.